Biogen Inc at Cowen Healthcare Conference (Virtual) Transcript
Good morning, and welcome once again to Cowen and Company's hopefully only virtual health care conference. I'm Phil Nadeau, Biotech Analyst here at Cowen, and it's my pleasure to moderate a fireside chat with Biogen. We have Michel Vounatsos, the CEO of Biogen with us today, as well as AL Sandrock, Executive Vice President of R&D.
Questions & Answers
So maybe over to you for the first question. Can you discuss your vision for Biogen over the next 5 years? How is the company going to create shareholder value? And what do you think differentiates Biogen as an investment versus other large-cap biotechs?
Thank you, Phil. And before we begin, I would like to make -- to point out that I will be making some forward-looking statements, which are based on current
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
